Press "Enter" to skip to content

Posts published in “Current Event”

Failure of once-promising Alzheimer’s drug reinforces doubts about amyloid beta | Med City News


"It had made its way into two Phase III trials thanks to Phase Ib data demonstrating its efficacy at reducing plaques of the peptide amyloid beta — a defining feature of Alzheimer’s disease — with observable clinical benefit to boot. But last month, Biogen and its partner, Japan’s Eisai, shocked the world by halting the Phase III studies, ENGAGE and EMERGE , after a futility analysis by the program’s independent data monitoring committee showed the trials were likely to fail."

Former NFL Wife on Her Husband’s Battle with CTE

"Former NFL wife and author of “After the Cheering Stops,” Cyndy Feasel discusses CTE, sports’ injuries and what parents should know about the impact of head injuries on their children."

‘Young Blood’ Researchers Are Still in the Pursuit to Stall Aging, Slow Alzheimer’s | Being Patient


"Earlier this year, the F.D.A. issued a warning to Ambrosia, a company that was selling plasma transfusions of 'young blood' to elderly people, suggesting it may stop aging. While the F.D.A. announced there is 'no proven clinical benefit' of these transfusions, it’s not the first time the practice has been pursued: Stanford researchers published a study on young blood transfusions 2017."a @href="https://www.beingpatient.com/alkahest-young-blood-chronokines/"> Read the full story at beingpatient.com

Top 10 Alzheimer’s Disease Stories of 2018 | Alzheimer’s News Today


"Throughout 2018, Alzheimer’s News Today brought you stories of important discoveries, treatment developments, clinical trials, and other events related to Alzheimer’s disease. As we look forward to providing more news to those living with Alzheimer’s as well as their family members and caregivers this year, here are the 10 most-read stories of 2018."

National campaign ‘Yes. I live with dementia’ aims to improve Alzheimer understanding | Saanich News


"Building awareness to address stigma was the primary objective of Geoff and Annemarie Travers’ Camino for Alzheimer’s Awareness. Last fall the Sidney couple walked 900 km together from near Montpellier, France to Lugrono, Spain, and Geoff walked an additional 600 km westward to Santiago de Compostela. The experienced distance walkers purposely chose a longer distance as a reflection of the long and arduous journey experienced by people living with dementia – and their caregivers."

With search for Alzheimer’s drugs failing, tech firms try to offer solutions | Stat News


"The drug industry’s foundering search for an Alzheimer’s cure is fueling a parallel quest by technology companies to help patients and family caregivers cope with the disease by using virtual reality software, robotics, and novel communication tools.Several companies engaged in the effort gathered here on Wednesday to deliver a unified message: Waiting for pharma to deliver a miracle is a recipe for financial Armageddon, as the cost of treating Alzheimer’s is expected to quadruple, to more than $1 trillion in the U.S. by 2030, if no breakthrough treatments reach the market."